Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-01-31 to 2023-02-22
Current total value of award: $1003.89
Description: 4559812321!ZOLADEX 3.6 MG IMPLANT SYRNS